CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
Alphabet Inc. Class C (GOOGL.US) releases Gemini 3.8 Live dual models: voice AI enters the era of "reasoning while conversing," with benchmark scores surpassing OpenAI and SpaceXAI.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-4139 Tablets Receive Drug Clinical Trial Approval Notice
Jiangsu Hengrui Pharmaceuticals (01276): Recaticimab for Injection Receives Drug Clinical Trial Approval Notice
Alphabet Inc. Class C (GOOGL.US) releases Gemini 3.8 Live dual models: voice AI enters the era of "reasoning while conversing," with benchmark scores surpassing OpenAI and SpaceXAI.
Jiangsu Hengrui Pharmaceuticals (01276): HRS-4139 Tablets Receive Drug Clinical Trial Approval Notice
Jiangsu Hengrui Pharmaceuticals (01276): Recaticimab for Injection Receives Drug Clinical Trial Approval Notice
RECOMMEND
